Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
KronosMD Inc’s CEO Files Provisional Patent Application for an Advanced Ultrasound Dental Digital Impression System
March 23, 2023 10:22 ET
|
Kronos Advanced Technologies Inc.
Parkersburg, WV, March 23, 2023 (GLOBE NEWSWIRE) -- Parkersburg, WV, March 23, 2023 /GlobeNewswire/ -- KronosMD, INC., a subsidiary of Kronos Advanced Technologies Inc (OTC MARKETS: KNOS) ("KNOS"...
Doctors Destroyed by Abuse of Clinical Practice Guidelines, according to Journal of American Physicians and Surgeons (AAPS)
March 21, 2023 11:19 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 21, 2023 (GLOBE NEWSWIRE) -- Clinical practice guidelines (CPGs) are intended to improve patient care, but hospitals that conduct sham peer reviews have become adept at misusing...
Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
March 20, 2023 08:28 ET
|
Revive Therapeutics Ltd.
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research...
Todos Medical Supports Long COVID Awareness Day
March 15, 2023 14:27 ET
|
Todos Medical Ltd.
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions...
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
March 15, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
March 07, 2023 08:30 ET
|
Dyadic International, Inc.
Dosing of all patients was completed at the end of February No Serious Adverse Events (SAE’s) have been reported Phase 1 clinical initial safety and antibody response update expected in Q2, 2023 ...
AIM ImmunoTech Issues Letter to Stockholders
March 06, 2023 08:45 ET
|
AIM ImmunoTech Inc.
Year marked by noteworthy operational execution and clinical development progress across pipeline Company reiterates commitment to continued communication and activity with the investment and...
Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS
March 02, 2023 16:01 ET
|
Veru Inc.
MIAMI, FL, March 02, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for...
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
March 01, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Kronos’ FDA Cleared Air Purifiers May Provide the Solution To Women's Health Initiative (WHI) Published Research On Air Pollution And Decreased Bone Mineral Density.
March 01, 2023 06:18 ET
|
Kronos Advanced Technologies Inc.
Parkersburg, WV, March 01, 2023 (GLOBE NEWSWIRE) -- Parkersburg, WV March 1, 2023 /GlobeNewswire/ KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), innovation-driven...